CDX2 as a Prognostic Biomarker in Colon Cancer.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 27248630)

Published in N Engl J Med on June 02, 2016

Authors

Laurent Chiche1, Darawan Rinchai2, Damien Chaussabel2

Author Affiliations

1: Hôpital Européen, Marseille, France l.chiche@hopital-europeen.fr.
2: Sidra Medical and Research Center, Doha, Qatar.

Articles citing this

CDX2 as a Prognostic Biomarker in Colon Cancer. N Engl J Med (2016) 0.75

Articles cited by this

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med (2016) 8.53